Yudi Miao1, Qiaojiajie Zhao2, Chengliang Li3
1Department of Hematology; 2Blood Research Department, Shaanxi Provincial people's Hospital, Xi’an; 3Department of General Practice, Guangzhou First People's Hospital, Guangzhou, China.For correspondence:- Chengliang Li Email: lichengliang79@sina.com
Accepted: November 2022 Published: 29 December 2022
Citation: Miao Y, Zhao Q, Li C. MiR-26 targeting methyltetrahydrofolate reductase inhibits the proliferation of acute myeloid leukemia cells via JAK/STAT pathway. Trop J Pharm Res 2022; 21(12):2501-2506 doi: 10.4314/tjpr.v21i12.1
© 2022 The authors.
This is an Open Access article that uses a funding model which does not charge readers or their institutions for access and distributed under the terms of the Creative Commons Attribution License (http://creativecommons.org/licenses/by/4.0) and the Budapest Open Access Initiative (http://www.budapestopenaccessinitiative.org/read), which permit unrestricted use, distribution, and reproduction in any medium, provided the original work is properly credited..
Archives
News Updates